Eric Joel Jusino Belen
Pharmacist · Lajas, PR
Eric Joel Jusino Belen is a pharmacist with a practice address in Lajas, Puerto Rico, and NPI 1770345522, issued on Jan 26, 2024. Check the license (Puerto Rico 008160, as entered in NPPES) with the Puerto Rico board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Eric Joel Jusino Belen
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 008160 PR
Self-reported in NPPES; status is on the state search - Practice location
- 3700 Carr 116 # 101, Lajas, PR 00667
- Phone
- (787) 899-8719
- Enumerated
- Jan 26, 2024
- Record last updated
- Jan 26, 2024
- Entity
- Type 1 · individual
Verify Eric Joel Jusino Belen in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Puerto Rico board licenses this profession
Search for license 008160Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 77% of the cost of the top drugs
25 Medicare Part D claims for 23 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Boostrix Tdap12 claims
- Shingrix12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
11 pharmacist records list a practice address in Lajas
They are 11 of the 124 NPPES records with a practice address in Lajas, and 3,180 pharmacist records in Puerto Rico.
All 11 in Lajas → All 3,180 in Puerto Rico → Every provider in Lajas →
Other pharmacist records in Puerto Rico
- Gilda Abad, RPHSan Juan, PR1891865796
- Hiba Aboukheir, PHARMDRio Grande, PR1851152128
- Nicole Abrams Santiago, PHARMDSan Juan, PR1700471042
- Damaris Abreu, RPHIsabela, PR1871629576
- Sonia Abreu, RPHIsabela, PR1821124926
- Agnes AcevedoCorozal, PR1013851187
- Astrid Acevedo, 3726Yauco, PR1396892600
- Carmen Acevedo, RPHUtuado, PR1518908102
- Ilia Acevedo, RPHAguada, PR1982769493
- Jorge Acevedo, PHARMACISTLares, PR1114144896
Common questions
What is Eric Joel Jusino Belen's NPI number?
Eric Joel Jusino Belen's National Provider Identifier (NPI) is 1770345522, issued on Jan 26, 2024. An NPI identifies a provider in billing; it is not a license.
Where is Eric Joel Jusino Belen located?
The NPPES record lists a practice address at 3700 Carr 116 # 101, Lajas, PR, 00667. Phone: (787) 899-8719. Providers update this record themselves, so call before visiting.
How can I verify Eric Joel Jusino Belen's license?
NPPES lists Puerto Rico license number 008160, as entered by the provider. Search the Puerto Rico board that licenses this profession; the NPPES record confirms identity only.
How much does Eric Joel Jusino Belen prescribe under Medicare Part D?
In 2024, Eric Joel Jusino Belen had 25 Medicare Part D claims for 23 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.